New Role for Human α-Defensin 5 in the Fight against Hypervirulent Clostridium difficile Strains

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Infection and Immunity

• Publication date

  2014-12-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/IAI.02955-14PMID 25547793PMCID PMC4333456
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clostridium difficile infection is associated with increased risk of death and prolonged hospitalization in children.

  2013influential reference
• Relationship Between Bacterial Strain Type, Host Biomarkers, and Mortality in Clostridium difficile Infection

  2013influential reference
• Duodenal infusion of donor feces for recurrent Clostridium difficile.

  2013cited by this paper
• Antimicrobial Peptides and Innate Immunity

  2013influential reference
• Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins.

  2012cited by this paper
• Functional Determinants of Human Enteric α-Defensin HD5

  2012cited by this paper
• Critical Role for MyD88-Mediated Neutrophil Recruitment during Clostridium difficile Colitis

  2012cited by this paper
• Clostridium difficile infection

  2012cited by this paper
• Bacterial Stimulation of the TLR-MyD88 Pathway Modulates the Homeostatic Expression of Ileal Paneth Cell α-Defensins

  2012cited by this paper
• Immune responses to Clostridium difficile infection.

  2012influential reference
• α‐Defensins in human innate immunity

  2012influential reference
• Clostridium difficile clinical isolates exhibit variable susceptibility and proteome alterations upon exposure to mammalian cationic antimicrobial peptides.

  2012influential reference
• Burden of Clostridium difficile on the Healthcare System

  2012cited by this paper
• PrsW Is Required for Colonization, Resistance to Antimicrobial Peptides, and Expression of Extracytoplasmic Function σ Factors in Clostridium difficile

  2011cited by this paper
• Multifunctional cationic host defence peptides and their clinical applications

  2011influential reference
• Clostridium difficile infection: epidemiology, risk factors and management

  2011cited by this paper
• Comparison of Strain Typing Results for Clostridium difficile Isolates from North America

  2011cited by this paper
• The dlt operon confers resistance to cationic antimicrobial peptides in Clostridium difficile.

  2011influential reference
• Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis

  2011cited by this paper
• Clostridium difficile infection in Europe: a hospital-based survey.

  2011cited by this paper
• Nucleotide-Binding Oligomerization Domain 1 Mediates Recognition of Clostridium difficile and Induces Neutrophil Recruitment and Protection against the Pathogen

  2011cited by this paper
• Clostridium difficile Infection: A Comprehensive Review

  2011influential reference
• Bacterial resistance mechanisms against host defense peptides

  2011influential reference
• Microbiota-immune system interaction: an uneasy alliance.

  2011cited by this paper
• Identification of a Genetic Locus Responsible for Antimicrobial Peptide Resistance in Clostridium difficile

  2010influential reference
• First report of hypervirulent strains polymerase chain reaction ribotypes 027 and 078 causing severe Clostridium difficile infection in Italy.

  2010cited by this paper
• Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality.

  2010cited by this paper
• The Changing Epidemiology of Clostridium difficile Infections

  2010cited by this paper
• Clostridium difficile Isolates Resistant to Fluoroquinolones in Italy: Emergence of PCR Ribotype 018

  2010cited by this paper
• Damage of the Bacterial Cell Envelope by Antimicrobial Peptides Gramicidin S and PGLa as Revealed by Transmission and Scanning Electron Microscopy

  2010cited by this paper
• Diversity of moxifloxacin resistance during a nosocomial outbreak of a predominantly ribotype ARU 027 Clostridium difficile diarrhea.

  2009cited by this paper
• α-Defensins in Enteric Innate Immunity

  2009cited by this paper
• Free energies of molecular bound states in lipid bilayers: lethal concentrations of antimicrobial peptides.

  2009cited by this paper
• Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium

  2009cited by this paper
• Antibacterial activity of human defensins on anaerobic intestinal bacterial species: a major role of HBD-3.

  2009cited by this paper
• Biological activity and structural aspects of PGLa interaction with membrane mimetic systems.

  2009cited by this paper
• Enteric defensins are essential regulators of intestinal microbial ecology

  2009cited by this paper
• Human alpha-defensins inhibit Clostridium difficile toxin B.

  2008cited by this paper
• Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface

  2008cited by this paper
• Secreted enteric antimicrobial activity localises to the mucus surface layer

  2008influential reference
• Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea.

  2008cited by this paper
• Emergence and Control of Fluoroquinolone-Resistant, Toxin A–Negative, Toxin B–Positive Clostridium difficile

  2007cited by this paper
• Defensins and other antimicrobial peptides in inflammatory bowel disease

  2007cited by this paper
• Alpha-defensins block the early steps of HIV-1 infection: interference with the binding of gp120 to CD4.

  2007cited by this paper
• Editor's quiz: Sigmoid stricture in a 39-year-old female.

  2007cited by this paper
• A flow cytometric assay to monitor antimicrobial activity of defensins and cationic tissue extracts.

  2006influential reference
• The co-evolution of host cationic antimicrobial peptides and microbial resistance

  2006cited by this paper
• Crystal structures of human α‐defensins HNP4, HD5, and HD6

  2006cited by this paper
• Antibacterial Activity and Specificity of the Six Human α-Defensins

  2005cited by this paper
• Reduced Paneth cell alpha-defensins in ileal Crohn's disease.

  2005cited by this paper
• Antibacterial activity and specificity of the six human {alpha}-defensins.

  2005cited by this paper
• Reduced Paneth cell α-defensins in ileal Crohn's disease

  2005cited by this paper
• Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense.

  2004cited by this paper
• Enteric Salmonella Infection Inhibits Paneth Cell Antimicrobial Peptide Expression

  2003cited by this paper
• Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin

  2003cited by this paper
• Paneth cell trypsin is the processing enzyme for human defensin-5

  2002influential reference
• Molecular characterization of the surface layer proteins from Clostridium difficile

  2001cited by this paper
• Secretion of microbicidal α-defensins by intestinal Paneth cells in response to bacteria

  2000cited by this paper
• Antibacterial Action of Structurally Diverse Cationic Peptides on Gram-Positive Bacteria

  2000influential reference
• Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria.

  2000cited by this paper
• Broad-spectrum antimicrobial activity of human intestinal defensin 5

  1997cited by this paper
• Detection of erythromycin-resistant determinants by PCR

  1996cited by this paper
• Evaluation of the suitability of bis-(1,3-dibutylbarbituric acid) trimethine oxonol, (diBA-C4(3)-), for the flow cytometric assessment of bacterial viability.

  1995cited by this paper
• Morphology of defensin-treated Staphylococcus aureus

  1995cited by this paper
• Detection of capsule in strains of Clostridium difficile of varying virulence and toxigenicity.

  1990cited by this paper
• Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity.

  1989cited by this paper
• Clostridium difficile in patients with cystic fibrosis.

  1985influential reference

• Combating Bacterial Infections with Vitamin D-Induced Antimicrobial Peptides.

  2026cites this paper
• The Black Soldier Fly Hermetia illucens Larva Presents an Antimicrobial Activity in Response to Clostridioides difficile Exposure

  2025cites this paper
• Virulence factors, antibiotic susceptibility and sequence type distribution of hospital-associated Clostridioides difficile isolates in Israel, 2020–2022

  2024cites this paper
• The Function and Modification of Human Defensin 5.

  2023cites this paper
• Clostridioides difficile infection: An emerging zoonotic disease

  2022cites this paper
• Battling Enteropathogenic Clostridia: Phage Therapy for Clostridioides difficile and Clostridium perfringens

  2022cites this paper
• Effective inhibition of Clostridioides difficile by the novel peptide CM-A

  2021cites this paper
• Bacteriophage endolysins as a potential weapon to combat Clostridioides difficile infection

  2020cites this paper
• Antimicrobial efficacy of Cecropin A (1-7)- Melittin and Lactoferricin (17-30) against multi-drug resistant Salmonella Enteritidis.

  2020cites this paper
• The value of antimicrobial peptides in the age of resistance.

  2020cites this paper
• A Novel Bacteriophage Lysin-Human Defensin Fusion Protein Is Effective in Treatment of Clostridioides difficile Infection in Mice

  2019influential citation
• HYBRIDIZED POLYMERIC NANO-ASSEMBLIES: KEY INSIGHTS INTO ADDRESSING MDR INFECTIONS

  2019cites this paper
• Clostridioides difficile ribotype 106: A systematic review of the antimicrobial susceptibility, genetics, and clinical outcomes of this common worldwide strain.

  2019cites this paper
• Advances in the diagnosis and treatment of Clostridium difficile infections

  2018cites this paper
• REGULATORY SYSTEMS OF STRUCTURAL-FUNCTIONAL UNITS OF SKIN IN NORM AND PATHOLOGY

  2018cites this paper
• Identifizierung inhibitorischer Peptide gegen die Toxine von Clostridium difficile aus humanem Hämofiltrat

  2018cites this paper
• Oral Administration of Probiotics Increases Paneth Cells and Intestinal Antimicrobial Activity

  2018cites this paper
• Endogenous antimicrobial factors in the treatment of infectious diseases

  2017cites this paper
• Human Antimicrobial Peptides in Bodily Fluids: Current Knowledge and Therapeutic Perspectives in the Postantibiotic Era

  2017cites this paper
• α-Defensin 5 gene expression is regulated by gut microbial metabolites

  2017cites this paper
• Bile Acid Administration Elicits an Intestinal Antimicrobial Program and Reduces the Bacterial Burden in Two Mouse Models of Enteric Infection

  2017cites this paper
• Perspectives for clinical use of engineered human host defense antimicrobial peptides

  2017cites this paper
• A Review of Experimental and Off-Label Therapies for Clostridium difficile Infection

  2016influential citation
• Virulence factors of Clostridium difficile and their role during infection.

  2016cites this paper
• Neutrophil-mediated inflammation in the pathogenesis of Clostridium difficile infections.

  2016cites this paper
• Diagnosing Clostridium difficile-associated diarrhea using enzyme immunoassay : the clinical significance of toxin negativity in glutamate dehydrogenase-positive patients

  2016cites this paper
• Defensins, lectins, mucins, and secretory immunoglobulin A: microbe-binding biomolecules that contribute to mucosal immunity in the human gut

  2016cites this paper
• Visualizing the attack of bacteria by the antimicrobial peptide human defensin 5

  2016cites this paper
• SEVERE CLOSTRIDIUM DIFFICILE INFECTIONS. A SYSTEMATIC LITERATURE -review-

  2016cites this paper
• Clostridium difficile PCR Ribotype 018, a Successful Epidemic Genotype

  2015cites this paper
• Molecular Defense Mechanisms during Urinary Tract Infection

  2015cites this paper
• Memory B Cells Encode Neutralizing Antibody Specific for Toxin B from the Clostridium difficile Strains VPI 10463 and NAP1/BI/027 but with Superior Neutralization of VPI 10463 Toxin B

  2015cites this paper
• Mammalian Antimicrobial Peptides: Promising Therapeutic Targets Against Infection and Chronic Inflammation.

  2015cites this paper
• Antimicrobial Peptides in 2014

  2015cites this paper
• Antimicrobial peptides and infectious diseases

  2015cites this paper
• MIT Open Access Articles Defensins, lectins, mucins, and secretory immunoglobulin A: microbe-binding biomolecules that contribute to mucosal immunity in the human gut

  year unknowncites this paper
• Infection and Drug Resistance Dovepress

  year unknowncites this paper